Energy Recovery: Great Balance Sheet, Terrible Everything Else

# Energy Recovery: Great Balance Sheet, Terrible Everything Else

Here's a fun game: find me the last time a company's revenue fell 57% year-over-year and the stock barely blinked. Energy Recovery pulled that off on August 5, and the muted reaction should worry you more than a violent selloff would. When the market shrugs at a number that bad, it's either because everyone saw it coming or because nobody's paying close enough attention to care. With ERII, given that only two analysts bother modeling this thing, I'd bet on the latter.

Let's not bury the lede: Q2 CY2026 revenue came in at $12.0 million, down 57.2% from a year ago, and the company swung from a $2.1 million profit last year to a net loss this quarter. That's not a soft patch — that's a business falling off a cliff, driven by delayed Middle East megaprojects that were supposed to be the whole point of owning this stock. Desalination revenue reportedly cratered roughly 80%. Q1 wasn't pretty either. TTM sales are now down nearly 15%, and the deceleration is accelerating, not stabilizing.

The stock has followed the numbers down, just with a lag. Shares are sitting at fresh 52-week lows near $7.77, down 57.6% from the 52-week high, trading 30.5% below the 200-day moving average, and printing a textbook lower-highs, lower-lows pattern that stretches back to the $16–18 zone from late 2025. There is no meaningful chart support until the low $7s, and honestly, maybe not even there. Sell-side is finally catching up: a rating downgrade to effectively neutral, and a price target that's been sliced from $11 down to $8 in three separate cuts. Forward EPS estimates have been taken out to the woodshed — the growth estimate has been slashed from 4275% to 771% to 269% to 197% in successive revisions, which tells you everything about how unreliable the "recovery is coming" narrative has been so far.

So why isn't this a screaming sell?

Because the balance sheet is doing something the income statement isn't: telling the truth calmly. ERII is sitting on $61.4 million in cash against just $8.2 million in debt, with a current ratio north of 8x. Gross margins are still excellent — 74.7% in Q2, 65.4% on a trailing basis — proof that whatever's wrong here, it isn't pricing power on the PX technology. And somehow, despite the P&L looking like a car crash, the company generated $15.4 million in free cash flow in Q2 alone, roughly $35.6 million over the first half, largely on working-capital release. That's the kind of dissonance that keeps a stock from becoming a zero even when the headline numbers are this ugly.

Then there's the bull case that refuses to die: a 2.9x book-to-bill ratio reported earlier this year, which — if you squint — suggests this is a timing problem, not a demand problem, and that the backlog will eventually convert into recognized revenue. Management's July 28 move to lease (not buy) a new Saudi manufacturing facility fits that story: keep CapEx light ($3–6 million guided for 2026), stay close to the core desalination market, and wait for the megaprojects to un-stick. It's a reasonable long-term thesis. It's also the exact same thesis that's been wrong for at least two consecutive disastrous quarters now, with an interim CEO citing "limited forward visibility" on the very projects the bulls are counting on.

That's the tension in one sentence: the backlog story hasn't been falsified, but it also hasn't paid off, and patience has been expensive. A forward P/E near 47x on repeatedly-slashed estimates and a PEG pushing 60 aren't numbers you back up the truck on. Anyone leaning on the more aggressive bullish price forecasts for this name should know those models have been wrong far more often than right on ERII specifically — directional accuracy in the 0–30% range on short horizons. Ignore them.

The honest call here is a hold, anchored around $8.50–$9.00, not a value trap and not a falling knife — just a company where the cash cushion buys time the revenue line hasn't earned yet. Q3 results, whenever they land in late October or early November, will tell you whether the Middle East pipeline is finally unclogging or whether "book-to-bill" is just a nicer way of saying "IOU." Until then, this is a watch-and-wait name, not a conviction trade. Don't confuse a quiet stock price with a healthy business — sometimes the market's just too bored to sell.